The expanding demand for specific immunological study and therapeutic creation has spurred significant progress in recombinant signal molecule manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently manufactured using diverse expression methods, including prokaryotic hosts, higher cell populations, and